SYNCHRONOUS BILATERAL BREAST CARCINOMA
Clinical trials for SYNCHRONOUS BILATERAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SYNCHRONOUS BILATERAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for SYNCHRONOUS BILATERAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop aggressive breast cancer in its tracks
Disease control OngoingThis phase 3 study tests whether adding tucatinib to the targeted therapy T-DM1 can better prevent HER2-positive breast cancer from coming back in high-risk patients. About 1,056 participants who still have cancer after initial treatment will receive either T-DM1 alone or T-DM1 p…
Matched conditions: SYNCHRONOUS BILATERAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 04:38 UTC
-
Landmark breast cancer study finds chemo not needed for many women with positive nodes
Disease control OngoingThis large phase 3 trial studied over 5,000 women with hormone receptor-positive, HER2-negative breast cancer that had spread to 1-3 lymph nodes. Participants received standard hormone therapy (tamoxifen or an aromatase inhibitor) either alone or with chemotherapy. The goal was t…
Matched conditions: SYNCHRONOUS BILATERAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:36 UTC